Dr. Binita Shah was awarded her MD from NYU School of Medicine and received a Masters of Science in Clinical Investigation concomitant with her clinical training. She then completed two years of a post-doctoral research fellowship with funding from the American College of Cardiology Foundation and the NIH T32 Program. 

Dr. Shah joined the Interventional Cardiology faculty at NYU in 2013 and is currently Assistant Professor of Medicine, Director of Internal Medicine Residency Research, and Associate Director of Research in the Cardiac Catheterization Laboratory at NYU. She conducts clinical translational research and utilizes a multi-disciplinary approach to the treatment of coronary artery disease and acute coronary syndrome with a focus on optimization of the underlying inflammatory milieu. She was PI of the VA-funded Colchicine-PCI trial and NIH-funded ColCorona-US study, and is currently PI of the NIH-funded CLEAR SYNERGY (OASIS 9) Biospecimen Substudy.